Arranz, M. J., Collier, D., Sodhi, M., et al (1995) Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet, 346, 281–282.
Arranz, M. J., Munro, J., Sham, P., et al (1998) Meta analysis of studies on variation in 5-HT2A receptors and clozapine response. Schizophrenia Research, 32, 93–99.
Chou, W. H., Yan, F. X., de Leon, J., et al (2000) Extension of a pilot study: impact from the P450 2D6 polymorphism on outcome and costs associated with severe mental illness. Journal of Clinical Psychopharmacology, 20, 246–251.
Cozza, K. L. & Armstrong, S. C. (2001) The Cytochrome P450 System. Drug Interaction Principles for Medical Practice. Washington, DC: American Psychiatric Publishing.
Elexperu-Camiruaga, J., Buxton, N., Kandula, V., et al (1995) Susceptibility to astrocytoma and meningioma: influence of allelism at glutathione S-transferase, GSTT1 and GSTM1 and cytochrome P450, CYP2D6 loci. Cancer Research, 55, 4237–4239.
Fakhoury, W. K., Wright, D. & Wallace, M. (2001) Prevalence and extent of distress of adverse effects of antipsychotics among callers to a United Kingdom National Mental Health Helpline. International Clinical Psychopharmacology, 16, 153–162.
Griffin, J. P. (1997) The cost of adverse drug reactions. Adverse Drug Re actions and Toxicological Reviews, 16, 75–78.
Hellewell, J. S. (2002) Patients' subjective experiences of antipsychotics: clinical relevance. CNS Drugs, 16, 457–471.
Lazarou, J., Pomeranz, P. H. & Corey, P. N. (1998) Incidence of adverse drug reactions in hospitalised patients: a meta-analysis of prospective studies. JAMA, 279, 1200–1205.
Mcleod, H. L., Krynetski, E.Y., Relling, M.V., et al (2000) Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukaemia, 14, 567–572.
Meyer, U. A., Amrein, R., Balant, L. P., et al (1996) Antidepressants and drug-metabolizing enzyme – expert group report. Acta Psychiatrica Scandinavica, 93, 71–79.
Perry, P. J. (2000) Therapeutic drug monitoring of atypical antipsychotics. Is it of potential clinical value?
CNS Drugs, 13, 167–171.
Richelson, E. (1997) Pharmacokinetic drug interactions of the new antidepressants: a review of the effects on the metabolism of other drugs. Mayo Clinic Proceedings, 72, 835–847.
van Aken, J., Schmedders, M., Feuerstein, G., et al (2003) Prospects and limits of pharmacogenetics. The thiopurine methyltransferase (TPMT) experience. American Journal of Pharmacogenomics, 3, 147–155.
Wolf, C. R., Smith, G. S. & Smith, R. L. (2000) Pharmacogenetics. BMJ, 320, 987–990.